Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Avadel Pharmaceuticals PLC (NASDAQ:AVDL)

9.61
Delayed Data
As of Sep 22
 +0.01 / +0.10%
Today’s Change
8.14
Today|||52-Week Range
13.94
-7.51%
Year-to-Date
No recent news for Avadel Pharmaceuticals PLC.

Today’s Trading

Previous close9.60
Today’s open9.60
Day’s range9.60 - 10.01
Volume199,950
Average volume (3 months)152,735
Market cap$385.2M
Dividend yield--
Data as of 3:59pm ET, 09/22/2017

Growth & Valuation

Earnings growth (last year)-200.25%
Earnings growth (this year)+795.83%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)-13.04%
P/E ratio16.0
Price/Sales2.86
Price/Book9.40

Competitors

 Today’s
change
Today’s
% change
TLGTTeligent Inc+0.10+1.48%
IOVAIovance Biotherapeut...+0.70+10.00%
TTPHTetraphase Pharmaceu...-0.29-4.24%
DEPODepomed Inc-0.02-0.34%
Data as of 4:00pm ET, 09/22/2017

Financials

Next reporting dateNovember 6, 2017
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$149.8M
Annual profit (last year)-$41.2M
Net profit margin-27.47%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
Michael Shannon Anderson
Chief Financial Officer &
Senior Vice President
Michael F. Kanan
Corporate headquarters
Dublin, Dublin

Forecasts